PURPOSE OF REVIEW: Recent evidence has linked n-3 polyunsaturated fatty acid (PUFA) supplementation with dramatic alterations of mitochondrial phospholipid membranes and favorable changes in mitochondrial function. In the present review, we examine the novel effects of n-3 PUFA on mitochondria, with an emphasis on cardiac mitochondrial phospholipids. RECENT FINDINGS: There is growing evidence that dietary n-3 PUFA, particularly docosahexaenoic acid (DHA), has profound effects on mitochondrial membrane phospholipid composition and mitochondrial function. Supplementation with n-3 PUFA increases membrane phospholipid DHA and depletes arachidonic acid, and can increase cardiolipin, a tetra-acyl phospholipid that is unique to mitochondrial and essential for optimal mitochondrial function. Recent studies show that supplementation with DHA decreases propensity for cardiac mitochondria to undergo permeability transition, a catastrophic event often leading to cell death. This finding provides a potential mechanism for the cardioprotective effect of DHA. Interestingly, other n-3 PUFAs that modify membrane composition to a lesser extent have substantially less of an effect on mitochondria and do not appear to directly protect the heart. SUMMARY: Current data support a role for n-3 PUFA supplementation, particularly DHA, on mitochondria that are strongly associated with changes in mitochondrial phospholipid composition.
PURPOSE OF REVIEW: Recent evidence has linked n-3 polyunsaturated fatty acid (PUFA) supplementation with dramatic alterations of mitochondrialphospholipid membranes and favorable changes in mitochondrial function. In the present review, we examine the novel effects of n-3 PUFA on mitochondria, with an emphasis on cardiac mitochondrialphospholipids. RECENT FINDINGS: There is growing evidence that dietary n-3 PUFA, particularly docosahexaenoic acid (DHA), has profound effects on mitochondrial membrane phospholipid composition and mitochondrial function. Supplementation with n-3 PUFA increases membrane phospholipidDHA and depletes arachidonic acid, and can increase cardiolipin, a tetra-acyl phospholipid that is unique to mitochondrial and essential for optimal mitochondrial function. Recent studies show that supplementation with DHA decreases propensity for cardiac mitochondria to undergo permeability transition, a catastrophic event often leading to cell death. This finding provides a potential mechanism for the cardioprotective effect of DHA. Interestingly, other n-3 PUFAs that modify membrane composition to a lesser extent have substantially less of an effect on mitochondria and do not appear to directly protect the heart. SUMMARY: Current data support a role for n-3 PUFA supplementation, particularly DHA, on mitochondria that are strongly associated with changes in mitochondrialphospholipid composition.
Authors: Genevieve C Sparagna; Chris A Johnson; Sylvia A McCune; Russell L Moore; Robert C Murphy Journal: J Lipid Res Date: 2005-03-16 Impact factor: 5.922
Authors: Michael Schlame; Richard I Kelley; Annette Feigenbaum; Jeffrey A Towbin; Paul M Heerdt; Thomas Schieble; Ronald J A Wanders; Salvatore DiMauro; Thomas J J Blanck Journal: J Am Coll Cardiol Date: 2003-12-03 Impact factor: 24.094
Authors: Karen M O'Shea; Ramzi J Khairallah; Genevieve C Sparagna; Wenhong Xu; Peter A Hecker; Isabelle Robillard-Frayne; Christine Des Rosiers; Tibor Kristian; Robert C Murphy; Gary Fiskum; William C Stanley Journal: J Mol Cell Cardiol Date: 2009-08-22 Impact factor: 5.000
Authors: Genevieve C Sparagna; Adam J Chicco; Robert C Murphy; Michael R Bristow; Christopher A Johnson; Meredith L Rees; Melissa L Maxey; Sylvia A McCune; Russell L Moore Journal: J Lipid Res Date: 2007-04-10 Impact factor: 5.922
Authors: Girma Asemu; Kelly A O'Connell; James W Cox; Erinne R Dabkowski; Wenhong Xu; Rogerio F Ribeiro; Kadambari C Shekar; Peter A Hecker; Sharad Rastogi; Hani N Sabbah; Charles L Hoppel; William C Stanley Journal: Am J Physiol Heart Circ Physiol Date: 2012-12-15 Impact factor: 4.733
Authors: Erinne R Dabkowski; Kelly A O'Connell; Wenhong Xu; Rogerio F Ribeiro; Peter A Hecker; Kadambari Chandra Shekar; Caroline Daneault; Christine Des Rosiers; William C Stanley Journal: Cardiovasc Drugs Ther Date: 2013-12 Impact factor: 3.727
Authors: E Madison Sullivan; Edward Ross Pennington; William D Green; Melinda A Beck; David A Brown; Saame Raza Shaikh Journal: Adv Nutr Date: 2018-05-01 Impact factor: 8.701